Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
NEKTAR THERAPEUTICS has filed 1,955 SEC EDGAR filings since 14 Feb 1996

SEC filing history

Showing 201-225 of 1,000 matching filings.

Per page
25
Current page
9
SC 13G File 005-45385

SC 13G

Filing date
15 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
14 Mar 2024
Reporting date
05 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-24006

CURRENT REPORT

Filing date
04 Mar 2024
Reporting date
04 Mar 2024
Next action
Verify source filing
4

4

Filing date
22 Feb 2024
Reporting date
20 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
22 Feb 2024
Reporting date
20 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
22 Feb 2024
Reporting date
20 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-24006

144 filing

Filing date
20 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-24006

144 filing

Filing date
20 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-24006

144 filing

Filing date
20 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-24006

CURRENT REPORT

Filing date
16 Feb 2024
Reporting date
12 Feb 2024
Next action
Verify source filing
SC 13G/A File 005-45385

SC 13G/A

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-45385

SC 13G/A

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-45385

SC 13G/A filing

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-45385

SCHEDULE 13G/A

Filing date
13 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-24006

CURRENT REPORT

Filing date
10 Jan 2024
Reporting date
10 Jan 2024
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Dec 2023
Reporting date
13 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Dec 2023
Reporting date
13 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Dec 2023
Reporting date
13 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-24006

144 filing

Filing date
15 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-24006

CURRENT REPORT

Filing date
27 Nov 2023
Reporting date
24 Nov 2023
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Nov 2023
Reporting date
17 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Nov 2023
Reporting date
17 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Nov 2023
Reporting date
17 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .